Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA therapy for asthma.

Joel N Kline1

  • 1Department of Medicine, University of Iowa, 200 Newton Road, Iowa City, IA 52242, USA. joel-kline@uiowa.edu

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary

New DNA-based asthma therapies are emerging, including antisense oligonucleotides and gene transfer. While still in preclinical stages, CpG oligonucleotides show promise for asthma treatment with ongoing clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.

Chest·2021
Same author

Giants in Chest Medicine: Donald C. Zavala, MD, FCCP.

Chest·2019
Same author

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2019
Same author

Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.

The European respiratory journal·2017
Same author

A four-dimensional computed tomography comparison of healthy and asthmatic human lungs.

Journal of biomechanics·2017
Same author

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.

The Journal of allergy and clinical immunology·2017

Area of Science:

  • Molecular biology
  • Immunology
  • Pharmacology

Background:

  • Asthma treatment is increasingly focused on molecular targets.
  • Recent research explores DNA-based therapeutic strategies for asthma.

Purpose of the Study:

  • To review emerging DNA-based therapeutic approaches for asthma.
  • To highlight preclinical studies utilizing DNA facets for asthma treatment.

Main Methods:

  • Review of preclinical studies on DNA-based asthma therapeutics.
  • Identification of specific DNA-based strategies: antisense oligonucleotides, gene transfer, CpG oligodeoxynucleotides.

Main Results:

  • Preclinical studies demonstrate potential of DNA-based approaches.
  • Antisense oligonucleotides target GATA-3 and stem cell factor.
  • Gene transfer explores interleukin-18 delivery.
  • CpG oligodeoxynucleotides modulate T-helper cell responses (Th2/Th1).

Conclusions:

  • Several DNA-based therapeutic avenues are under investigation for asthma.
  • No clinical asthma experience reported yet for these specific DNA-based methods.
  • Clinical trials are underway for CpG oligonucleotides in asthma therapy.

Related Experiment Videos